Africa’s Biggest Drugmaker Can Help Ease Obesity Medicine Supply Crunch
- Aspen can make some of the sought-after drugs in South Africa
- Global demand for new weight-loss drugs outstrips supply
Africa’s biggest drugmaker could potentially help ease a growing supply crunch for the world’s hottest obesity medications.
Aspen Pharmacare Holdings Ltd., which signed a deal last year to distribute and promote Eli Lilly & Co.’s blockbuster diabetes drug Mounjaro throughout Southern Africa, has the capacity to boost availability of the most in-demand shots globally, chief executive officer Stephen Saad said in an interview with Bloomberg. This could take the form of so-called fill and finish services, where the drug is packaged for use, he said.